Navigation Links
Parents: Quit Smoking and Your Children Are Less Likely to Smoke
Date:5/28/2008

Odds of youth smoking uptake greatly reduced if parents quit

LONDON, May 28 /PRNewswire-FirstCall/ -- If both parents of a child never smoked, research shows that a child's odds of daily smoking are reduced by more than 70 percent(1) compared to when both parents continue to smoke. And if both parents were smokers but quit, those same odds are reduced by nearly 40 percent.(1) Additional research shows that mothers who quit are less likely to have children who start smoking.(2)

As global leaders in tobacco control commemorate World No Tobacco Day (WNTD) on May 31st, the rallying cry is to prevent young people from starting to smoke. While the 2008 theme, "Tobacco-Free Youth" calls for additional limitations on the marketing practices of cigarette marketers and other comprehensive changes, a major determining factor of children's tobacco use is the smoking status of their parents.

"By quitting smoking, parents can play a major role in helping to end the vicious cycle of passing addiction from generation to generation," said Howard Marsh, M.D., medical director, GlaxoSmithKline Consumer Healthcare. "Parents who want to take this important step on May 31st should get help from proven smoking cessation treatments such as therapeutic nicotine to increase their chances of staying off cigarettes for good."

Smoking remains one of the leading causes of preventable death and disease and one of the most powerful and important addictions to break. That said, many smokers can't do it alone. Evidence-based treatments such as therapeutic nicotine including (US: NicoDerm(R) CQ(R), Nicorette and Commit) (ex-US) NiQuitin(R) and Nicabate(R) in combination with counseling offers a significantly better chance of quitting versus cold turkey.(3)

Consider these statistics:

-- Therapeutic nicotine smoking cessation aids, Nicorette(R) gum (United

States only), NicoDerm CQ patch and Commit(R) lozenge, and NiQuitin and

Nicabate brands outside of the United States, have helped over 6.5

million people around the world quit smoking and, as a result, have

significantly reduced their exposure to the risks of cancer and other

smoking-related diseases.(4)

-- More than one billion patches, lozenges and gums were sold in 2007 to

help smokers quit.(5)

-- Quitters using therapeutic nicotine can double their chances of success

versus quitting without help.

-- More than 110 studies involving approximately 40,000 smokers have

demonstrated the safety of therapeutic nicotine, even in populations

with specific health conditions, such as diabetes, high blood pressure,

lung disease, and existing heart disease.(6)

-- International and national guidelines from the United States, United

Kingdom and the World Health Organization (WHO) recommend therapeutic

nicotine as a first-line treatment for smoking addiction.(7)

-- Committed Quitters is the only free, tailored Web-based behavioral

support program that has been proven to increase a smoker's chances of

quitting. This program is available as Click2Quit in the UK.

-- More than 13 billion packs of cigarettes have gone un-sold as a result

of smokers quitting with therapeutic nicotine.(8)

GlaxoSmithKline's line of therapeutic nicotine products such as Nicorette gum (United States only), NicoDerm CQ patch and Commit lozenge, and NiQuitin and Nicabate brands outside of the United States, are easy to access in thousands of retail outlets and pharmacies worldwide. These products are designed specifically to break the daily addiction cycle by offering a gradual, controlled delivery of nicotine to the body, helping to relieve cravings and withdrawal symptoms.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) and Commit(R), NiQuitin and Nicabate, as well as many medicine cabinet staples such as Abreva(R), Aquafresh(R), Sensodyne(R) and Tums(R). GlaxoSmithKline Consumer Healthcare continues to develop innovative products to help all smokers find their best support system and achieve their goal of being cigarette free.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

NOTE: GlaxoSmithKline distributes Nicorette(R) gum, Nicoderm(R) patch and Commit(R) lozenge the United States. Outside of the U.S., its smoking cessation patch and lozenge are marketed as Nicabate(R) in Australia and NiQuitin(R) in other countries.

(1) Bricker, Leroux, et al; Nine-year prospective relationship between

parental smoking cessation and children's daily smoking; Addiction,

98, 585-593

(2) Chassin, Presson, et al; Parental Smoking Cessation and Adolescent

Smoking; Journal of Pediatric Psychology, Vol.27, No.6, 2002, pp.

585-593

(3) Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and

Dependence. Clinical Practice Guideline. Rockville, MD:

(4) Projection of the Cumulative Number of Global GSKCH NRT Quitters

(5) Projection of the Cumulative Number of Global GSKCH NRT Quitters

(6) Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine

replacement therapy for smoking cessation. Cochrane Database of

Systematic Reviews 2008, Issue 1. Art. No.: CD000146. DOI:

10.1002/14651858.CD000146.pub3.

(7) 2008 U.S. Public Health Service Guideline: Treating Tobacco Use and

Dependence; early draft released in October 2007.

(8) Projection of the Cumulative Number of Global GSKCH NRT Quitters

US Contacts: Samantha Schwarz, GolinHarris

312-622-1124

sschwarz@golinharris.com

Jennifer May, GlaxoSmithKline Consumer Healthcare

412-200-3729

Jennifer.L.May@gsk.com

Contacts Outside

of the US: Claire Dixon EU , 44 20 8047 4296,

Claire.E.Dixon@gsk.com

Graham Read, Australia/New Zealand,

612 9684 0295, Graham.A.Read@gsk.com


'/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Tips for Parents: Teaching Children to Resolve Conflicts
2. Parents: With Halloween Candy, Focus on Choice and Time to Prevent Teeth Decay
3. Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D.
4. A Reminder to Parents: Early Dental Visits Essential to Childrens Health
5. Smoking may strongly increase long-term risk of eye disease
6. Smoking increases risks for head and neck cancers for men and women
7. Smoking Boosts Risk for Head, Neck Cancers
8. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
9. Passive smoking increases sleep disturbance among pregnant women
10. Teens who see more smoking in movies may have increased risk of becoming established smokers
11. Smoking in Movies May Put Teens at Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, 2017 , ... ... half of all Americans, yet poor sleep is likely not the only cause of ... these undesirable characteristics that make you look older or in poor health are likely ...
(Date:3/23/2017)... ... 23, 2017 , ... Corra Group is now offering exclusively ... Verisys through its FACIS and other services maintains the largest healthcare database ... are delighted to be able to offer these various products to our healthcare ...
(Date:3/23/2017)... McKinney, Texas (PRWEB) , ... March 23, 2017 ... ... Operations Command (USSOCOM) awarded Task Force Dagger Foundation the US Special Operations Command’s ... Thomas. During the presentation, General Thomas thanked Task Force Dagger Foundation for its ...
(Date:3/23/2017)... DC (PRWEB) , ... March 23, 2017 , ... News ... Dental Choice has helped score a major victory in Europe for public health and ... , Based on rigorous scientific research and the overwhelming support of European ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... an innovative patient - centric payment system, to expand its focus on patient ... the patient financial experience. , “At Ogden Clinic, we are working to ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Under ... Chinese pharmaceutical packaging market size increased year by ... From 2017 to 2021, the market size will ... is expected to outnumber RMB140 billion in 2021, ... the rapid development of biological agents and supporting ...
(Date:3/22/2017)... Pennsylvania , 22. März 2017 /PRNewswire/ ... unabhängige und weltweit tätige Anbieter von Produkten ... heute den Erwerb von EPL Archives Inc. ... Stoffe, der Kunden im kompletten Zyklus regulierter ... Verwahrung von Proben, Speicherung von Dokumenten und ...
(Date:3/22/2017)... 22, 2017  Applied BioMath ( www.appliedbiomath.com ), ... research and development, today announced the latest line-up ... 2017 is a day full of presentations, posters, ... (QSP) community. The focus is to learn about ... accelerating drug research and development. The ...
Breaking Medicine Technology: